Cargando…
Lobaplatin-Based Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastasis from Appendiceal and Colorectal Cancer: Safety and Efficacy Profiles
OBJECTIVE: This study aimed to evaluate the safety and efficacy of lobaplatin in hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastasis (PM) arising from colorectal or appendiceal cancer. MATERIALS AND METHODS: Patients with synchronous or metachronous PM who under...
Autores principales: | Pei, Wei, Zhou, Sicheng, Zhang, Jing, Zhou, Haitao, Chen, Haipeng, Bi, Jianjun, Zheng, Zhaoxu, Liu, Zheng, Jiang, Zheng, Wang, Zheng, Liu, Qian, Wang, Xishan, Liang, Jianwei, Feng, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699987/ https://www.ncbi.nlm.nih.gov/pubmed/33262658 http://dx.doi.org/10.2147/CMAR.S281434 |
Ejemplares similares
-
Can Elderly Patients with Peritoneal Metastasis Induced by Appendiceal or Colorectal Tumours Benefit from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?
por: Zhou, Sicheng, et al.
Publicado: (2021) -
High-grade postoperative complications affect survival outcomes of patients with colorectal Cancer peritoneal metastases treated with Cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy
por: Zhou, Sicheng, et al.
Publicado: (2021) -
Does the primary tumour location affect the prognosis of patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?
por: Chen, Haipeng, et al.
Publicado: (2021) -
Lobaplatin in Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: Safety and Efficacy Profiles
por: Zhong, Yuxin, et al.
Publicado: (2020) -
Lobaplatin-based prophylactic hyperthermic intraperitoneal chemotherapy for T4 gastric cancer patients: A retrospective clinical study
por: Zhong, Yuxin, et al.
Publicado: (2023)